Harrow, Inc. (HROW) Financials

HROW Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 311.8 million 241.8 million
2023-09-30 286.1 million 210.7 million
2023-06-30 224.0 million 201.9 million
2023-03-31 217.5 million 196.0 million

HROW Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 8.5 million 4.2 million
2023-09-30 -21.3 million 4.5 million
2023-06-30 3.3 million 5.4 million
2023-03-31 -139.2 million 1.6 million

HROW Net Income

No data available :(

HROW Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 82.8 million - 7.3 million
2023-09-30 65.6 million - 7.5 million
2023-06-30 22.8 million 169.7 million 7.7 million
2023-03-31 19.2 million 168.9 million 7.9 million

HROW Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 35.4 million
2023-09-30 34.3 million
2023-06-30 30.2 million
2023-03-31 30.3 million

HROW Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 203000 3.3 million 26.2 million -
2023-09-30 20.1 million 1.4 million 21.0 million -
2023-06-30 1.2 million 1.2 million 20.0 million -
2023-03-31 131.0 million 734000 15.9 million -

HROW Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 36.4 million 11.3 million
2023-09-30 34.3 million 10.1 million
2023-06-30 33.5 million 10.0 million
2023-03-31 26.1 million 8.3 million

HROW

Price: $10.38

52 week price:
7.60
28.25

Earnings Per Share: -0.75 USD

P/E Ratio: -26.11

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 114053

Market Capitalization: 447.7 million

Links: